Liver Cancer Diagnostics Market Size To Accrue $ 15.93 Billi...| MENAFN.COM

Friday, 12 August 2022 11:49 GMT

Liver Cancer Diagnostics Market Size To Accrue $ 15.93 Billion By 2027


(MENAFN- Ameliorate Digital Consultancy)

Market Study Report presents latest report on global Liver Cancer Diagnostics Market, which evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2021-2027.

Global Liver Cancer Diagnostics Market to reach USD 15.93 billion by 2027.Global Liver Cancer Diagnostics Market is valued approximately USD 9.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.50 % over the forecast period 2021-2027.

Request a sample of this premium report at:

Liver cancer diagnostics is an advanced liver cancer diagnosis which is done by Chemotherapy and low-dose radiation may control the cancer's spread and ease pain. The rise in number of awareness program about early diagnosis of liver cancer is expected to rise the demand for liver cancer diagnostics market in the forecasted period. In 2018, the National Cancer Institute (NCI) funded a research program at Michigan Medicine for USD 33.4 million to alter the existing liver cancer surveillance and facilitate early detection of liver cancer in the U.S. Furthermore, increase in number of liver cancer patients is driving the growth for the market. According to the American Cancer Society, in 2021, around 42,230 new cases of liver cancer are diagnosed in the U.S., which will lead to around 30,230 deaths. Also, research and development programs and technological advancement is creating vast opportunity for the market. As, in June 2019, CancerSEEK a liquid biopsy test was designed by the researchers at Johns Hopkins University. The test was designed to diagnose multiple cancers including stomach, liver, ovarian, and esophageal among others an early stage, facilitating early treatment. However, high cost of technological advancement of liver cancer diagnostic solutions which might restrain the growth of the lover cancer diagnostics market in the forecasted period 2021-2027.

The key regions considered for the global Liver Cancer Diagnostics market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to the well-established healthcare infrastructure, excellent healthcare insurance policies, and high adoption of innovative diagnostic tests. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as high prevalence of hepatitis in emerging countries including India and China would create lucrative demand for liver cancer diagnostics market.

Major market player included in this report are:

Abbott Laboratories

  • Hoffmann-La Roche Ltd.
  • Qiagen N.V.

    Thermo Fisher Scientific, Inc.

    Siemens Healthineers

    Becton Dickinson & Company

    Illumina, Inc.

    Koninklijke Philips N.V.

    Epigenomics AG

    Fujifilm Medical Systems U.S.A., Inc.

    The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

    By Test Type Outlook:

    Laboratory Test

    Imaging Tests

    Endoscopy

    Biopsy

    Others

    By End-Use Outlook:

    Hospitals & Diagnostic Laboratories

    Academic & Research Institutes

    Pharmaceutical & CRO Laboratories

    By Region:

    North America

    U.S.

    Canada

    Europe

    UK

    Germany

    France

    Spain

    Italy

    ROE

    For More Details on this Report At:

    About Us:

    Market Study Report is a hub for market intelligence products and services.

    We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

    Our customers partner with Market Study Report to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

    If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report is the platform that can help you in achieving any of these objectives.

    MENAFN05082022004660010643ID1104649968


    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.